g4 platinum continuous glucose monitoring system (Dexcom Inc)
86
Structured Review
Dexcom Inc
g4 platinum continuous glucose monitoring system
G4 Platinum Continuous Glucose Monitoring System, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/g4+platinum+continuous+glucose+monitoring+system/dexcom+g4+platinum/us12525351-185-23-22
Average 86 stars, based on 1 article reviews
G4 Platinum Continuous Glucose Monitoring System, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/g4+platinum+continuous+glucose+monitoring+system/dexcom+g4+platinum/us12525351-185-23-22
Average 86 stars, based on 1 article reviews
g4 platinum continuous glucose monitoring system - by Bioz Stars,
2026-09
86/100 stars
Images
Related Articles
Software:Article Title: Remote monitoring of analyte measurements Article Snippet: .. In one implementation, the sensor system 8 and receiver 102 comprise the DexCom Article Title: Remote monitoring of analyte measurements Article Snippet: .. In one implementation, the sensor system 8 and receiver 102 comprise the DexCom Concentration Assay:Article Title: Systems and methods for managing glycemic variability Article Snippet: .. Any of the glucose monitoring devices and systems described herein can be used to monitor the host's glucose concentration, such as the DexCom other:Article Title: Clinical Performance Evaluation of Continuous Glucose Monitoring Systems: A Scoping Review and Recommendations for Reporting. Article Snippet: The accuracy and efficacy of the Article Title: Correlation Between Glycemic Variability in Patients With Intracerebral Hemorrhage and Neurological Deterioration. Article Snippet: Background: Glycemic variability and its management hold significant prognostic implications in clinical practice for patient outcomes.. The aim of this study is to analyze the correlation between glycemic variability and the deterioration of neurological function in patients with intracerebral hemorrhage (ICH), to provide evidence-based support for the treatment and care of clinical ICH patients.. Methods: Patients with ICH admitted to our hospital between January 2022 and August 2024 were subjected to the National Institutes of Health Stroke Scale (NIHSS) scoring upon admission and discharge. |